期刊文献+

中西医结合治疗高血压急症临床分析 被引量:5

Clinical observation on treating hypertension emergency in the integrative medicine
下载PDF
导出
摘要 目的:探讨高血压急症采用中西医结合治疗临床效果。方法:本次共选择100例高血压急症患者作研究对象,均为我院2012年9月-2013年9月收治,随机分组,就单纯西医治疗(对照组)与中西医结合治疗(观察组)预后进行比较。结果:两组用药前、用药30min收缩压监测值无明显差异(P>0.05),后60min、120min、180min、240min观察组血压平稳下降,用时较短,对照组波动较大,用时较长,两组均达血压治疗终点。观察组恶心、呕吐、头痛、眩晕等不良事件发生率低于对照组,差异有统计学意义(P<0.05)。结论:依据高血压急症特点,临床在常规医药治疗的基础上,加用中药治疗,可改善预后,保障用药安全,提高患者生存质量,具有非常积极的应用价值。 Objective:To observe clinical effects of integrative medicine on treating hypertension emergency. Methods:100 patients were divided into western medicine group and integrative medicine group. Results:The lower blood pressure, shorter time, adverse events in the integrative medicine group were lower than western medicine, the difference was significant (P〈0.05). Conclusion:The integrative medicine can improve the prognosis, ensure the safety of medicine, improve the quality of survival, is worthy of clinical application.
出处 《中医临床研究》 2014年第10期86-87,共2页 Clinical Journal Of Chinese Medicine
关键词 中西医结合 高血压急症 预后观察 The integrative medicine Hypertensive emergency Prognosis observation
  • 相关文献

参考文献5

二级参考文献12

  • 1王莹.乌拉地尔治疗缺血性心脏病并心力衰竭的临床观察[J].心血管康复医学杂志,2005,14(1):57-57. 被引量:5
  • 2陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 3Fauci A,Braunwald E,Kasper D,et al.王德柄,主译.哈里森内科学[M].北京:人民卫生出版社,2003:1760-1761.
  • 4Zink M, Gombotz H, Wasler A, et al. Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplan- tation [J]. J Heart Lung Transplant, 2002, 21 (3): 347- 353.
  • 5Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction ). J Am Coll Cardiol,1999,34:890-911.
  • 6Janczak J, Krupienicz A, Roszczyk E, et al. PRIMARY CORONARY ANGIOPLASTY versus THROMBOLYTIC THERAPY. Comparison of mortality in the acute phase of myocardial infarction - a single centre experience. Kardiol Pol, 2002,57:542-550.
  • 7Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevatian myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation ,2004,110 : e82-292.
  • 8Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet,2001,357 : 1385-1390.
  • 9ISIS-4 ( Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral monanitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet,1995, 345,669 -685.
  • 10Collins R, Peto R, Baigent C, et al. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med, 1997,336:847-860.

共引文献2700

同被引文献26

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部